Argent Biopharma Limited has released a press release.
MXC Enters Multi $M Australian Pharma Market
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- First $8m Binding Cosmetics Sales Agreement Signed
- $40 Million White-Label CBD Cosmetics Agreement Executed
- MXC Botanic Division Operational Update
- Major EU Pharma Supply Agreement Signed with Lenis
- Appendix 4E and Audited 2017 Financial Report
Later from Argent Biopharma
- First Varm Cosmo Binding Purchase Order Received
- Definitive Supply Agreement Executed with HL Pharma
- Binding Agreement to Supply $1m CBD Extract Annually
- New Year Launch of MGC Derma CBD Psoriasis Cream Confirmed
- MXC Operational Update
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma